![Genix Pharmaceuticals Corp](/common/images/company/TX_GENX.png)
Year End October 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 933k | 1.04M | 856k | 137k | 0 | 0 | 0 | 12k |
Operating Income | -114k | -239k | 134k | -78k | -469k | -1.39M | -860k | -4.19M |
Pre Tax Income | -129k | -243k | 134k | -164k | -718k | -1.65M | -1.07M | -4.4M |
Net Income | -129k | -243k | 134k | -164k | -718k | -1.65M | -1.07M | -4.4M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.003 | -0.006 | 0.004 | -0.004 | -0.012 | -0.028 | -0.018 | -0.074 |
EBIT | -114k | -239k | 134k | -78k | -469k | -1.39M | -860k | -4.19M |
EBITDA | -69k | -197k | 162k | -78k | -108k | -853k | -295k | -180k |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.